Log In
Print this Print this

Liposomal Bcl-2 (BP1002) (formerly BP-100-1.02)

  Manage Alerts
Collapse Summary General Information
Company Bio-Path Holdings Inc.
DescriptionLiposomal encapsulated oligonucleotide targeted to the translation initiation site of human Bcl-2 mRNA
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today